@article{2951599,
    title = "Adverse Event (AE) Management With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the STRATUS (TM) Trial: A Phase 3b Study Evaluating Safety and Efficacy in Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM)",
    author = "Cavo, M and Dimopoulos, MA and Moreau, P and Palumbo, A and Corradini, P and Weisel, K and Ocio, E and Doyen, C and Anttila, P and Raymakers, R and others",
    journal = "Clinical Lymphoma Myeloma and Leukemia",
    year = "2015",
    volume = "15",
    pages = "e264",
    publisher = "Elsevier"
}